NCT01147692已完成1 期
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Albiglutide in Healthy Adult Subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- The effect of albiglutide on the pharmacokinetics of simvastatin
研究概览
简要总结
This open-label study evaluates the pharmacokinetics of simvastatin when coadministered with albiglutide in healthy adult subjects. The primary objective is to assess the effect of albiglutide doses on the pharmacokinetics of simvastatin.
详细描述
This Phase I open-label study evaluates the pharmacokinetics of simvastatin when coadministered with albiglutide in healthy adult subjects. The primary objective is to assess the effect of albiglutide doses on the pharmacokinetics of simvastatin.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •no clinically significant diseases or clinically significant abnormal laboratory values
- •females must be of non-childbearing potential
- •body mass index (BMI) is >/=18 kg and ≤30 kg/m2
- •nonsmoker
- •negative drug screen
排除标准
- •positive test results for hepatitis B, hepatitis C or human immunodeficiency virus (HIV)
- •any clinically relevant abnormality
- •female subject is pregnant or breast-feeding
- •history of any anaphylactic reaction to any drug
- •history of significant cardiovascular or pulmonary dysfunction
- •current or chronic history of liver disease
- •history of alcohol or substance abuse
- •history of thyroid dysfunction or disease
- •history of gastrointestinal surgery or disease
- •history of pancreatitis
- •previously received any GLP-1 mimetic compound (e.g., exenatide)
结局指标
主要结局
The effect of albiglutide on the pharmacokinetics of simvastatin
时间窗: 42 days
次要结局
- The pertinent plasma pharmacokinetic parameters of simvastatin with and without albiglutide(42 days)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Drug Interaction Study With Albiglutide and WarfarinDiabetes Mellitus, Type 2NCT01147731GlaxoSmithKline16
已完成
1 期
A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.Rheumatoid ArthritisNCT00365001Hoffmann-La Roche23
已完成
1 期
An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .Diabetes Mellitus, Type 2NCT01077505GlaxoSmithKline16
已完成
1 期
MK0524B Bioequivalence Study (0524B-070)DyslipidemiaNCT00943124Merck Sharp & Dohme LLC220
已完成
1 期
Drug Interaction Study of Simvastatin and DabigatranHealthyNCT03728101Korea University Guro Hospital12